Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
15,480,759
-
Shares change
-
+879,512
-
Total reported value, excl. options
-
$242,692,929
-
Value change
-
+$18,073,157
-
Number of buys
-
29
-
Number of sells
-
17
-
Price
-
$15.68
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q3 2016
As of 30 Sep 2016 CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,480,759 shares of stock of the company.
Largest 10 holders included FMR LLC, PUTNAM INVESTMENTS LLC, DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, Tekla Capital Management LLC, Redmile Group, LLC, BVF INC/IL, VHCP Management II, LLC, BlackRock Fund Advisors, and Cormorant Asset Management, LLC.
This table shows 60 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.